Pembrolizumab for Early Triple-Negative Breast CancerPeter Schmid, Joyce O’Shaughnessy, Javier Cortés et al.|New England Journal of Medicine|2020Cited by 3.1k
Breast cancerNadia Harbeck, Fátima Cardoso, Frédérique Penault‐Llorca et al.|Nature Reviews Disease Primers|2019Cited by 2.9k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trialJavier Cortés, Gallardo Carlos, Sally Baron-Hay et al.|The Lancet|2020Cited by 1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAlessandra Gennari, Nadia Harbeck, Fabrice André et al.|Annals of Oncology|2021Cited by 1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Fátima Cardoso, Eric P. Winer, Shani Paluch–Shimon et al.|Annals of Oncology|2020Cited by 1.4k